These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 17338241)

  • 21. [Progression of leukoplakia is associated with changes in apoptotic and mitotic index as well as in p53 and Ki-67 expression].
    Kövesi G; Szende B
    Magy Onkol; 2002; 46(4):333-8. PubMed ID: 12563356
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor markers in stage P1 bladder cancer.
    Stavropoulos NE; Ioachim E; Charchanti A; Michael MC; Kitsiou E; Mihailidis I; Hastazeris K; Agnantis NJ
    Anticancer Res; 2001; 21(2B):1495-8. PubMed ID: 11396238
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does HER2 immunoreactivity provide prognostic information in locally advanced urothelial carcinoma patients receiving adjuvant M-VEC chemotherapy?
    Tsai YS; Tzai TS; Chow NH
    Urol Int; 2007; 79(3):210-6. PubMed ID: 17940352
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Mathematical evaluation of prognostic significance of clinico-morphological and immunohistochemical features of endometrioid adenocarcinoma].
    Razorenova TS; Samsonova EA; Pozharisskiĭ KM; Razorenov GI
    Vopr Onkol; 2007; 53(6):682-9. PubMed ID: 18416138
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic, predictive and therapeutic implications of HER2 in invasive epithelial ovarian cancer.
    Serrano-Olvera A; Dueñas-González A; Gallardo-Rincón D; Candelaria M; De la Garza-Salazar J
    Cancer Treat Rev; 2006 May; 32(3):180-90. PubMed ID: 16483720
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation of HER-2/neu protein overexpression with other prognostic and predictive factors in invasive ductal breast cancer.
    Ivkovic-Kapicl T; Knezevic-Usaj S; Djilas-Ivanovic D; Panjkovic M
    In Vivo; 2007; 21(4):673-8. PubMed ID: 17708365
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinicopathological and biological features of breast cancer in young females and their relationship with prognosis].
    Meng J; Lang RG; Fan Y; Fu L
    Zhonghua Zhong Liu Za Zhi; 2007 Apr; 29(4):284-8. PubMed ID: 17760256
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The relation between hypoxia-inducible factor (HIF)-1alpha expression with p53 expression and outcome in surgically treated supraglottic laryngeal cancer.
    Cabanillas R; Rodrigo JP; Secades P; Astudillo A; Nieto CS; Chiara MD
    J Surg Oncol; 2009 May; 99(6):373-8. PubMed ID: 19226532
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protein expression and amplification of AIB1 in human urothelial carcinoma of the bladder and overexpression of AIB1 is a new independent prognostic marker of patient survival.
    Luo JH; Xie D; Liu MZ; Chen W; Liu YD; Wu GQ; Kung HF; Zeng YX; Guan XY
    Int J Cancer; 2008 Jun; 122(11):2554-61. PubMed ID: 18246597
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TGF-betaRII, BAX, IGFIIR, caspase-5, hMSH3 and hMSH6 alterations are not associated with microsatellite instability or p53 mutations in invasive urothelial carcinoma of the urinary bladder.
    Saetta AA; Korkolopoulou P; Karlou M; Levidou G; Goudopoulou A; Thymara I; Stamatelli A; Tzivras M; Michalopoulos NV; Thomas-Tsagli E; Patsouris E
    Pathology; 2007 Aug; 39(4):425-32. PubMed ID: 17676485
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [New quantitative method for determining p53 protein in bladder carcinomas].
    Moreno Sierra J; Maestro de las Casas ML; Ortega Heredia MD; Chicharro Almarza J; Blanco Jiménez E; Silmi Moyano A; Resel Estévez L
    Arch Esp Urol; 1997 May; 50(4):347-53. PubMed ID: 9313043
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prognostic value of the immunohistochemical expression of: Ki67, p53, PCNA and Bcl2 in the superficial tumors of the bladder].
    Rammeh-Rommani S; Zermani R; Sfaxi M; Chabchoub A; Zouari B; Ayed M; Ben Jilani-Baltagi S
    Tunis Med; 2007 Jun; 85(6):509-12. PubMed ID: 17644907
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Combined surgery and radiotherapy in the treatment of ductal carcinoma in situ of the breast: preliminary results of the Hungarian multicenter prospective randomised study].
    Polgár C; Orosz Z; Kahán Z; Gábor G; Jani N; Cserni G; Hadijev J; Kulka J; Sulyok Z; Boross G; Lázár G; László Z; Diczházi C; Udvarhelyi N; Szabó E; Péntek Z; Major T; Fodor J
    Magy Onkol; 2008 Sep; 52(3):269-77. PubMed ID: 18845497
    [TBL] [Abstract][Full Text] [Related]  

  • 34. C-erbB-2 expression is a better predictor for survival than galectin-3 or p53 in early-stage breast cancer.
    Logullo AF; Lopes AB; Nonogaki S; Soares FA; Netto MM; Nishimoto IN; Brentani MM
    Oncol Rep; 2007 Jul; 18(1):121-6. PubMed ID: 17549356
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ki-67, p53 and epidermal growth factor receptor expression in early glottic cancer involving the anterior commissure treated with radiotherapy.
    Ahmed WA; Suzuki K; Imaeda Y; Horibe Y
    Auris Nasus Larynx; 2008 Jun; 35(2):213-9. PubMed ID: 17996416
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sensitivity and specificity of p53 protein detection by immunohistochemistry in patients with urothelial bladder carcinoma.
    Salinas-Sánchez AS; Atienzar-Tobarra M; Lorenzo-Romero JG; Sánchez-Sánchez F; Giménez-Bachs JM; Donate-Moreno MJ; Pastor-Navarro H; Hernández-Millán I; Segura-Martín M; Escribano-Martínez J
    Urol Int; 2007; 79(4):321-7. PubMed ID: 18025850
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aneuploidy and overexpression of Ki67 and p53 as markers for neoplastic progression in Barrett's esophagus: a case-control study.
    Sikkema M; Kerkhof M; Steyerberg EW; Kusters JG; van Strien PM; Looman CW; van Dekken H; Siersema PD; Kuipers EJ
    Am J Gastroenterol; 2009 Nov; 104(11):2673-80. PubMed ID: 19638963
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of ThinPrep cytology in the investigation of ki-67 index, p53 and HER-2 detection in fine-needle aspirates of breast tumors.
    Konofaos P; Kontzoglou K; Parakeva P; Kittas C; Margari N; Giaxnaki E; Pouliakis M; Kouraklis G; Karakitsos P
    J BUON; 2013; 18(2):352-8. PubMed ID: 23818345
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic value of microsatellite instability determined by immunohistochemical staining of hMSH2 and hMSH6 in urothelial carcinoma of the bladder.
    Mylona E; Zarogiannos A; Nomikos A; Giannopoulou I; Nikolaou I; Zervas A; Nakopoulou L
    APMIS; 2008 Jan; 116(1):59-65. PubMed ID: 18254781
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A study of breast cancer in young women: prognosis and prognostic factors.
    Saito E
    Nihon Geka Hokan; 1996 Nov; 65(4):133-44. PubMed ID: 9528272
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.